Stay updated on AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.

Latest updates to the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check29 days agoNo Change Detected
- Check65 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check79 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check87 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.